Report Detail
Global Spinal Biologics Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
- RnM4543438 |
- 25 July, 2023 |
- Global |
- 93 Pages |
- GIR (Global Info Research) |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Spinal Biologics market size was valued at USD 2572.4 million in 2022 and is forecast to a readjusted size of USD 3455.5 million by 2029 with a CAGR of 4.3% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Spinal Biologics market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Spinal Biologics market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Spinal Biologics market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Spinal Biologics market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Spinal Biologics market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023.
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Spinal Biologics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace.
This report profiles key players in the global Spinal Biologics market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Johnson & Johnson (Depuy Synthes), Orthofix Medical, Inc., Stryker Corporation, Zimmer Biomet and Arthrex, Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Spinal Biologics market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Minimally Invasive Surgery
Open Surgery
Market segment by Application
Hospitals
Spinal Surgery Centers
Others
Major players covered
Johnson & Johnson (Depuy Synthes)
Orthofix Medical, Inc.
Stryker Corporation
Zimmer Biomet
Arthrex, Inc.
Exactech, Inc.
Spine Wave, Inc.
Medtronic plc
NuVasive, Inc.
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Spinal Biologics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Spinal Biologics, with price, sales, revenue and global market share of Spinal Biologics from 2018 to 2023.
Chapter 3, the Spinal Biologics competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Spinal Biologics breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Spinal Biologics market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Spinal Biologics.
Chapter 14 and 15, to describe Spinal Biologics sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope of Spinal Biologics
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Spinal Biologics Consumption Value by Type: 2018 Versus 2022 Versus 2029
- 1.3.2 Minimally Invasive Surgery
- 1.3.3 Open Surgery
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Spinal Biologics Consumption Value by Application: 2018 Versus 2022 Versus 2029
- 1.4.2 Hospitals
- 1.4.3 Spinal Surgery Centers
- 1.4.4 Others
- 1.5 Global Spinal Biologics Market Size & Forecast
- 1.5.1 Global Spinal Biologics Consumption Value (2018 & 2022 & 2029)
- 1.5.2 Global Spinal Biologics Sales Quantity (2018-2029)
- 1.5.3 Global Spinal Biologics Average Price (2018-2029)
2 Manufacturers Profiles
- 2.1 Johnson & Johnson (Depuy Synthes)
- 2.1.1 Johnson & Johnson (Depuy Synthes) Details
- 2.1.2 Johnson & Johnson (Depuy Synthes) Major Business
- 2.1.3 Johnson & Johnson (Depuy Synthes) Spinal Biologics Product and Services
- 2.1.4 Johnson & Johnson (Depuy Synthes) Spinal Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.1.5 Johnson & Johnson (Depuy Synthes) Recent Developments/Updates
- 2.2 Orthofix Medical, Inc.
- 2.2.1 Orthofix Medical, Inc. Details
- 2.2.2 Orthofix Medical, Inc. Major Business
- 2.2.3 Orthofix Medical, Inc. Spinal Biologics Product and Services
- 2.2.4 Orthofix Medical, Inc. Spinal Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.2.5 Orthofix Medical, Inc. Recent Developments/Updates
- 2.3 Stryker Corporation
- 2.3.1 Stryker Corporation Details
- 2.3.2 Stryker Corporation Major Business
- 2.3.3 Stryker Corporation Spinal Biologics Product and Services
- 2.3.4 Stryker Corporation Spinal Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.3.5 Stryker Corporation Recent Developments/Updates
- 2.4 Zimmer Biomet
- 2.4.1 Zimmer Biomet Details
- 2.4.2 Zimmer Biomet Major Business
- 2.4.3 Zimmer Biomet Spinal Biologics Product and Services
- 2.4.4 Zimmer Biomet Spinal Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.4.5 Zimmer Biomet Recent Developments/Updates
- 2.5 Arthrex, Inc.
- 2.5.1 Arthrex, Inc. Details
- 2.5.2 Arthrex, Inc. Major Business
- 2.5.3 Arthrex, Inc. Spinal Biologics Product and Services
- 2.5.4 Arthrex, Inc. Spinal Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.5.5 Arthrex, Inc. Recent Developments/Updates
- 2.6 Exactech, Inc.
- 2.6.1 Exactech, Inc. Details
- 2.6.2 Exactech, Inc. Major Business
- 2.6.3 Exactech, Inc. Spinal Biologics Product and Services
- 2.6.4 Exactech, Inc. Spinal Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.6.5 Exactech, Inc. Recent Developments/Updates
- 2.7 Spine Wave, Inc.
- 2.7.1 Spine Wave, Inc. Details
- 2.7.2 Spine Wave, Inc. Major Business
- 2.7.3 Spine Wave, Inc. Spinal Biologics Product and Services
- 2.7.4 Spine Wave, Inc. Spinal Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.7.5 Spine Wave, Inc. Recent Developments/Updates
- 2.8 Medtronic plc
- 2.8.1 Medtronic plc Details
- 2.8.2 Medtronic plc Major Business
- 2.8.3 Medtronic plc Spinal Biologics Product and Services
- 2.8.4 Medtronic plc Spinal Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.8.5 Medtronic plc Recent Developments/Updates
- 2.9 NuVasive, Inc.
- 2.9.1 NuVasive, Inc. Details
- 2.9.2 NuVasive, Inc. Major Business
- 2.9.3 NuVasive, Inc. Spinal Biologics Product and Services
- 2.9.4 NuVasive, Inc. Spinal Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.9.5 NuVasive, Inc. Recent Developments/Updates
3 Competitive Environment: Spinal Biologics by Manufacturer
- 3.1 Global Spinal Biologics Sales Quantity by Manufacturer (2018-2023)
- 3.2 Global Spinal Biologics Revenue by Manufacturer (2018-2023)
- 3.3 Global Spinal Biologics Average Price by Manufacturer (2018-2023)
- 3.4 Market Share Analysis (2022)
- 3.4.1 Producer Shipments of Spinal Biologics by Manufacturer Revenue ($MM) and Market Share (%): 2022
- 3.4.2 Top 3 Spinal Biologics Manufacturer Market Share in 2022
- 3.4.2 Top 6 Spinal Biologics Manufacturer Market Share in 2022
- 3.5 Spinal Biologics Market: Overall Company Footprint Analysis
- 3.5.1 Spinal Biologics Market: Region Footprint
- 3.5.2 Spinal Biologics Market: Company Product Type Footprint
- 3.5.3 Spinal Biologics Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Spinal Biologics Market Size by Region
- 4.1.1 Global Spinal Biologics Sales Quantity by Region (2018-2029)
- 4.1.2 Global Spinal Biologics Consumption Value by Region (2018-2029)
- 4.1.3 Global Spinal Biologics Average Price by Region (2018-2029)
- 4.2 North America Spinal Biologics Consumption Value (2018-2029)
- 4.3 Europe Spinal Biologics Consumption Value (2018-2029)
- 4.4 Asia-Pacific Spinal Biologics Consumption Value (2018-2029)
- 4.5 South America Spinal Biologics Consumption Value (2018-2029)
- 4.6 Middle East and Africa Spinal Biologics Consumption Value (2018-2029)
5 Market Segment by Type
- 5.1 Global Spinal Biologics Sales Quantity by Type (2018-2029)
- 5.2 Global Spinal Biologics Consumption Value by Type (2018-2029)
- 5.3 Global Spinal Biologics Average Price by Type (2018-2029)
6 Market Segment by Application
- 6.1 Global Spinal Biologics Sales Quantity by Application (2018-2029)
- 6.2 Global Spinal Biologics Consumption Value by Application (2018-2029)
- 6.3 Global Spinal Biologics Average Price by Application (2018-2029)
7 North America
- 7.1 North America Spinal Biologics Sales Quantity by Type (2018-2029)
- 7.2 North America Spinal Biologics Sales Quantity by Application (2018-2029)
- 7.3 North America Spinal Biologics Market Size by Country
- 7.3.1 North America Spinal Biologics Sales Quantity by Country (2018-2029)
- 7.3.2 North America Spinal Biologics Consumption Value by Country (2018-2029)
- 7.3.3 United States Market Size and Forecast (2018-2029)
- 7.3.4 Canada Market Size and Forecast (2018-2029)
- 7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
- 8.1 Europe Spinal Biologics Sales Quantity by Type (2018-2029)
- 8.2 Europe Spinal Biologics Sales Quantity by Application (2018-2029)
- 8.3 Europe Spinal Biologics Market Size by Country
- 8.3.1 Europe Spinal Biologics Sales Quantity by Country (2018-2029)
- 8.3.2 Europe Spinal Biologics Consumption Value by Country (2018-2029)
- 8.3.3 Germany Market Size and Forecast (2018-2029)
- 8.3.4 France Market Size and Forecast (2018-2029)
- 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
- 8.3.6 Russia Market Size and Forecast (2018-2029)
- 8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
- 9.1 Asia-Pacific Spinal Biologics Sales Quantity by Type (2018-2029)
- 9.2 Asia-Pacific Spinal Biologics Sales Quantity by Application (2018-2029)
- 9.3 Asia-Pacific Spinal Biologics Market Size by Region
- 9.3.1 Asia-Pacific Spinal Biologics Sales Quantity by Region (2018-2029)
- 9.3.2 Asia-Pacific Spinal Biologics Consumption Value by Region (2018-2029)
- 9.3.3 China Market Size and Forecast (2018-2029)
- 9.3.4 Japan Market Size and Forecast (2018-2029)
- 9.3.5 Korea Market Size and Forecast (2018-2029)
- 9.3.6 India Market Size and Forecast (2018-2029)
- 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
- 9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
- 10.1 South America Spinal Biologics Sales Quantity by Type (2018-2029)
- 10.2 South America Spinal Biologics Sales Quantity by Application (2018-2029)
- 10.3 South America Spinal Biologics Market Size by Country
- 10.3.1 South America Spinal Biologics Sales Quantity by Country (2018-2029)
- 10.3.2 South America Spinal Biologics Consumption Value by Country (2018-2029)
- 10.3.3 Brazil Market Size and Forecast (2018-2029)
- 10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
- 11.1 Middle East & Africa Spinal Biologics Sales Quantity by Type (2018-2029)
- 11.2 Middle East & Africa Spinal Biologics Sales Quantity by Application (2018-2029)
- 11.3 Middle East & Africa Spinal Biologics Market Size by Country
- 11.3.1 Middle East & Africa Spinal Biologics Sales Quantity by Country (2018-2029)
- 11.3.2 Middle East & Africa Spinal Biologics Consumption Value by Country (2018-2029)
- 11.3.3 Turkey Market Size and Forecast (2018-2029)
- 11.3.4 Egypt Market Size and Forecast (2018-2029)
- 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
- 11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
- 12.1 Spinal Biologics Market Drivers
- 12.2 Spinal Biologics Market Restraints
- 12.3 Spinal Biologics Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
- 12.5 Influence of COVID-19 and Russia-Ukraine War
- 12.5.1 Influence of COVID-19
- 12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
- 13.1 Raw Material of Spinal Biologics and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Spinal Biologics
- 13.3 Spinal Biologics Production Process
- 13.4 Spinal Biologics Industrial Chain
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Spinal Biologics Typical Distributors
- 14.3 Spinal Biologics Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Spinal Biologics. Industry analysis & Market Report on Spinal Biologics is a syndicated market report, published as Global Spinal Biologics Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Spinal Biologics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
